| Bioactivity | PD117588 is a quinolone antibacterial agent with a broad range of antibacterial activity. PD117588 exhibits excellent activity against a variety of Gram-positive and Gram-negative bacteria from cancer patients, especially against all Gram-positive strains, including methicillin-resistant Staphylococcus aureus, coagulase-negative Staphylococci, and Enterococci. PD117588 is also very effective against most Gram-negative bacilli, although ciprofloxacin shows stronger activity against Pseudomonas aeruginosa. Compared with other quinolone antibiotics, the minimum inhibitory concentration of PD117588 outperforms most of the tested microorganisms, including imipenem and ceftazidime[1]. |
| CAS | 99734-97-1 |
| Formula | C20H23F2N3O3 |
| Molar Mass | 391.41 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. In-vitro activity of PD 117558, a new quinolone against bacterial isolates from cancer patients |
PD117588
CAS: 99734-97-1 F: C20H23F2N3O3 W: 391.41
PD117588 is a quinolone antibacterial agent with a broad range of antibacterial activity. PD117588 exhibits excellent ac
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.